Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 25, 2025

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.5K

Retinal vasculitis.

James T Rosenbaum1, Cailin H Sibley, Phoebe Lin

  • 1aDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Sciences University bDepartment of Medicine, Oregon Health & Sciences University cDepartment of Cell Biology, Oregon Health & Sciences University, Portland, Oregon, USA dLegacy Devers Eye Institute, Legacy Health System, Portland, Oregon, USA.

Current Opinion in Rheumatology
|March 6, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity.

npj drug discovery·2026
Same author

Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis.

American journal of ophthalmology·2026
Same author

One-year CALM Outcomes: Data From a Real-world Registry Study of the 0.18-mg Fluocinolone Acetonide Intravitreal Implant for the Treatment of Patients With Non-infectious Uveitis Affecting the Posterior Segment.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

Journal of vitreoretinal diseases·2026
Same author

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

JAMA ophthalmology·2026
Same author

Interpretable Deep Learning for OCT-Based Diagnosis of Vitreoretinal Lymphoma Versus Uveitis.

Translational vision science & technology·2026
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

This review clarifies retinal vasculitis for physicians, highlighting genetic links and imaging

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Vascular Biology

Background:

  • Retinal vasculitis often leads to miscommunication between ophthalmologists and rheumatologists.
  • A clear understanding of retinal vasculitis is essential for accurate diagnosis and treatment.

Purpose of the Study:

  • To establish a common understanding of retinal vasculitis.
  • To review recent studies and diagnostic advancements.

Main Methods:

  • Literature review of recent studies on retinal vasculitis.
  • Analysis of genetic factors, imaging techniques, and therapeutic outcomes.

Main Results:

  • Genetic basis identified for rare retinal vascular diseases (e.g., CAPN5, TREX1, TNFAIP3).

More Related Videos

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on: March 12, 2022

4.0K
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

8.5K

Related Experiment Videos

Last Updated: Nov 25, 2025

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.5K
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on: March 12, 2022

4.0K
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

8.5K
  • Behçet's disease is strongly linked to occlusive retinal vasculitis.
  • Advanced retinal imaging aids diagnosis and complication characterization.
  • Anti-TNF-alpha therapies (infliximab, adalimumab) show benefit for Behçet's disease.
  • Interferon and B-cell depletion (rituximab) may help other forms.

    • Conclusions:

    • Retinal vasculitis requires rheumatologist understanding.
    • Behçet's disease-associated vasculitis responds to anti-TNF therapy.
    • Other noninfectious retinal vasculitis forms necessitate different treatments.